PEPTIDES
The present invention relates to p2l derived peptides capable of inhibiting CDK/cyclin complexes, particularly cyclins A or E/CDK2, by modifying the interaction with their substrates. The peptides are derived from a C-terminal region of p2l. and display selectivity for cyclin/CDK2 inhibition over cy...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
06.05.2005
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!